Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
Hong, David S, Kang, Yoon-Koo, Borad, Mitesh, Sachdev, Jasgit, Ejadi, Samuel, Lim, Ho Yeong, Brenner, Andrew J, Park, Keunchil, Lee, Jae-Lyun, Kim, Tae-You, Shin, Sangjoon, Becerra, Carlos R, Falchook, Gerald, Stoudemire, Jay, Martin, Desiree, Kelnar, Kevin, Peltier, Heidi, Bonato, Vinicius, Bader, Andreas G, Smith, Susan, Kim, Sinil, O'Neill, Vincent, Beg, Muhammad S
Published in British journal of cancer (01.05.2020)
Published in British journal of cancer (01.05.2020)
Get full text
Journal Article
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
Motzer, Robert J, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Negrier, Sylvie, Prof, Oudard, Stephane, Prof, Gore, Martin E, Prof, Tarazi, Jamal, MD, Hariharan, Subramanian, MD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Rini, Brian I, MD
Published in The lancet oncology (01.05.2013)
Published in The lancet oncology (01.05.2013)
Get full text
Journal Article
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
Hutson, Thomas E, Prof, Lesovoy, Vladimir, Prof, Al-Shukri, Salman, Prof, Stus, Viktor P, Prof, Lipatov, Oleg N, Prof, Bair, Angel H, PhD, Rosbrook, Brad, MS, Chen, Connie, PharmD, Kim, Sinil, MD, Vogelzang, Nicholas J, Prof
Published in The lancet oncology (01.12.2013)
Published in The lancet oncology (01.12.2013)
Get full text
Journal Article
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
Rini, Brian I, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Kaprin, Andrey, Prof, Szczylik, Cezary, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Gorbunova, Vera A, Prof, Gore, Martin E, Prof, Rusakov, Igor G, Prof, Negrier, Sylvie, Prof, Ou, Yen-Chuan, Prof, Castellano, Daniel, MD, Lim, Ho Yeong, Prof, Uemura, Hirotsugu, Prof, Tarazi, Jamal, MD, Cella, David, PhD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Motzer, Robert J, MD
Published in The Lancet (British edition) (03.12.2011)
Published in The Lancet (British edition) (03.12.2011)
Get full text
Journal Article
Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial
Rini, Brian I, Prof, Melichar, Bohuslav, Prof, Ueda, Takeshi, Prof, Grünwald, Viktor, MD, Fishman, Mayer N, Prof, Arranz, José A, MD, Bair, Angel H, PhD, Pithavala, Yazdi K, PhD, Andrews, Glen I, MS, Pavlov, Dmitri, PhD, Kim, Sinil, MD, Jonasch, Eric, MD
Published in The lancet oncology (01.11.2013)
Published in The lancet oncology (01.11.2013)
Get full text
Journal Article
Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma
RINI, Brian I, WILDING, George, HUDES, Gary, STADLER, Walter M, KIM, Sinil, TARAZI, Jamal, ROSBROOK, Brad, TRASK, Peter C, WOOD, Laura, DUTCHER, Janice P
Published in Journal of clinical oncology (20.09.2009)
Published in Journal of clinical oncology (20.09.2009)
Get full text
Journal Article
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
Kindler, Hedy L, Dr, Ioka, Tatsuya, MD, Richel, Dirk J, MD, Bennouna, Jaafar, MD, Létourneau, Richard, MD, Okusaka, Takuji, MD, Funakoshi, Akihiro, MD, Furuse, Junji, MD, Park, Young Suk, MD, Ohkawa, Shinichi, MD, Springett, Gregory M, MD, Wasan, Harpreet S, MB, Trask, Peter C, PhD, Bycott, Paul, PhD, Ricart, Alejandro D, MD, Kim, Sinil, MD, Van Cutsem, Eric, MD
Published in The lancet oncology (01.03.2011)
Published in The lancet oncology (01.03.2011)
Get full text
Journal Article
The Cas9-gRNA ribonucleoprotein complex-mediated editing of pyrG in Ganoderma lucidum and unexpected insertion of contaminated DNA fragments
Eom, Hyerang, Choi, Yeon-Jae, Nandre, Rutuja, Han, Hui-Gang, Kim, Sinil, Kim, Minseek, Oh, Youn-Lee, Nakazawa, Takehito, Honda, Yoichi, Ro, Hyeon-Su
Published in Scientific reports (10.07.2023)
Published in Scientific reports (10.07.2023)
Get full text
Journal Article
Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
COHEN, Ezra E. W, ROSEN, Lee S, TORTORICI, Michael, SHALINSKY, David R, LIAU, Katherine F, COHEN, Roger B, VOKES, Everett E, KIES, Merrill S, FORASTIERE, Arlene A, WARDEN, Francis P, KANE, Madeleine A, SHERMAN, Eric, KIM, Sinil, BYCOTT, Paul
Published in Journal of clinical oncology (10.10.2008)
Published in Journal of clinical oncology (10.10.2008)
Get full text
Journal Article
Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis
Rini, Brian I, Garrett, May, Poland, Bill, Dutcher, Janice P, Rixe, Olivier, Wilding, George, Stadler, Walter M, Pithavala, Yazdi K, Kim, Sinil, Tarazi, Jamal, Motzer, Robert J
Published in Journal of clinical pharmacology (01.05.2013)
Published in Journal of clinical pharmacology (01.05.2013)
Get more information
Journal Article
Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors
RINI, Brian I, SCHILLER, Joan H, KIM, Sinil, RIXE, Olivier, FRUEHAUF, John P, COHEN, Ezra E. W, TARAZI, Jamal C, ROSBROOK, Brad, BAIR, Angel H, RICART, Alejandro D, OLSZANSKI, Anthony J, LETRENT, Kristen J
Published in Clinical cancer research (01.06.2011)
Published in Clinical cancer research (01.06.2011)
Get full text
Journal Article
Heterokaryosis, the main obstacle in the generation of PPO1-edited Agaricus bisporus by CRISPR/Cas9 system
Choi, Yeon Jae, Eom, Hyerang, Yang, Seong-Hyeok, Nandre, Rutuja, Kim, Sinil, Kim, Minseek, Oh, Youn-Lee, Nakazawa, Takehito, Honda, Yoichi, Ro, Hyeon-Su
Published in Scientia horticulturae (01.08.2023)
Published in Scientia horticulturae (01.08.2023)
Get full text
Journal Article
Comparative structural analysis on the mitochondrial DNAs from various strains of Lentinula edodes
Kim, Sinil, Eom, Hyerang, Nandre, Rutuja, Choi, Yeon Jae, Lee, Hwayong, Ryu, Hojin, Ro, Hyeon-Su
Published in Frontiers in microbiology (28.11.2022)
Published in Frontiers in microbiology (28.11.2022)
Get full text
Journal Article
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study
Rixe, Olivier, Prof, Bukowski, Ronald M, MD, Michaelson, M Dror, MD, Wilding, George, MD, Hudes, Gary R, MD, Bolte, Oliver, MD, Motzer, Robert J, MD, Bycott, Paul, DrPH, Liau, Katherine F, BS, Freddo, James, MD, Trask, Peter C, PhD, Kim, Sinil, MD, Rini, Brian I, MD
Published in The lancet oncology (01.11.2007)
Published in The lancet oncology (01.11.2007)
Get full text
Journal Article
Efficacy and Safety of Axitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Phase II Study
SCHILLER, Joan H, LARSON, Timothy, VON PAWEL, Joachim, IGNATIUS OU, S.-H, LIMENTANI, Steven, SANDLER, Alan, VOKES, Everett, KIM, Sinil, LIAU, Katherine, BYCOTT, Paul, OLSZANSKI, Anthony J
Published in Journal of clinical oncology (10.08.2009)
Published in Journal of clinical oncology (10.08.2009)
Get full text
Journal Article
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study
Spano, Jean-Philippe, Prof, Chodkiewicz, Catherine, MD, Maurel, Joan, MD, Wong, Ralph, MD, Wasan, Harpreet, MD, Barone, Carlo, Prof, Létourneau, Richard, MD, Bajetta, Emilio, MD, Pithavala, Yazdi, PhD, Bycott, Paul, DrPh, Trask, Peter, PhD, Liau, Katherine, BS, Ricart, Alejandro D, MD, Kim, Sinil, MD, Rixe, Olivier, Prof
Published in The Lancet (British edition) (21.06.2008)
Published in The Lancet (British edition) (21.06.2008)
Get full text
Journal Article
Molecular analysis of B mating type diversity in Lentinula edodes
Ha, Byeongsuk, Moon, Yoon Jung, Song, Yelin, Kim, Sinil, Kim, Minseek, Yoon, Cheol-Won, Ro, Hyeon-Su
Published in Scientia horticulturae (03.01.2019)
Published in Scientia horticulturae (03.01.2019)
Get full text
Journal Article
Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer
RUGO, Hope S, STOPECK, Alison T, BAIR, Angel H, SOULIERES, Denis, JOY, Anil A, CHAN, Stephen, VERMA, Shailendra, LLUCH, Anna, LIAU, Katherine F, KIM, Sinil, BYCOTT, Paul, ROSBROOK, Brad
Published in Journal of clinical oncology (20.06.2011)
Published in Journal of clinical oncology (20.06.2011)
Get full text
Journal Article
Conference Proceeding
Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from the global randomized Phase 3 AXIS trial
Ueda, Takeshi, Uemura, Hirotsugu, Tomita, Yoshihiko, Tsukamoto, Taiji, Kanayama, Hiroomi, Shinohara, Nobuo, Tarazi, Jamal, Chen, Connie, Kim, Sinil, Ozono, Seiichiro, Naito, Seiji, Akaza, Hideyuki
Published in Japanese journal of clinical oncology (01.06.2013)
Published in Japanese journal of clinical oncology (01.06.2013)
Get full text
Journal Article